Xofigo for Prostate Cancer

Xofigo for Prostate Cancer

The Food and Drug Administration has very recently approved a new pharmaceutical, Xofigo, for the treatment of late stage prostate cancer. The drug is a new hope for the treatment of a kind of cancer that affects more than 50% of men over 55 and over 90% of men over...
FDA approves Tradjenta to Treat Type 2 Diabetes

FDA approves Tradjenta to Treat Type 2 Diabetes

There’s some good news for type 2 diabetes patients. Firstly it was the Gastric Bypass Surgery considered to improve insulin reaction. And now, the new drug Tradjenta is used in combination with diet and exercise to help improve blood glucose levels amongst adults in...

Contrave: FDA Decision, Chances for Approval

Contrave is a treatment for obesity that consists of bupropion combined with naltrexone. An FDA advisory panel voted 13-7 for its approval in December.  In the end of January, it is going for an official FDA decision. Based on a variety of factors, we would hedge...